B16/F10 cells and were given 4 doses of treatments as indicated every third day starting at day 3 after tumor challenge. Data are representative of 2 independent experiments with 5-8 mice per group. i.p., intraperitonial treatment, i.t., intratumoral treatment. Error bars represent the mean ± SEM. **p<0.01, **p<0.001 (Mantel-Cox test) . Survival curve significance is calculated between anti-CTLA-4 plus vehicle and anti-CTLA-4 plus Pam3CSK4. 5 B16/F10 cells and were given 2 doses of treatments as indicated on day 9 and 12 after tumor challenge. Tumors were harvested at day 14 after tumor challenge and cumulative tumor weights of the indicated treatment groups in 2 of 3 independent experiments. (B) Individual tumor growth and (C) Survival of mice in each treatment group. Mice were challenged with 3x10 5 B16/F10 cells and were given 4 doses of treatments as indicated every third day starting at day 9 after tumor challenge. Data are representative of 1 of 2 experiments with 4-5 animals per group. *p<0.05***p<0.001 (Student ttest). 
